| | Univariate | Multivariate |
---|
Haplotypes | Freq. | aOR (95CI) | p-value (*) | q-value (**) | aOR (95CI) | p-value (*) | q-value (**) |
---|
LTNPs vs MPs |
AC | 0.366 | 0.85 (0.65; 1.10) | 0.218 | 0.284 | 0.85 (0.63; 1.15) | 0.292 | 0.378 |
TT | 0.307 | 1.45 (1.09; 1.93) |
0.009
|
0.027
| 2.32 (4.95; 20.8) |
0.018
| 0.054 |
AT | 0.321 | 0.86 (0.66; 1.13) | 0.284 | 0.284 | 0.87 (0.65; 1.18) | 0.378 | 0.378 |
LTNPs vs RPs |
AC | 0.361 | 0.74 (0.53; 1.04) | 0.080 | 0.120 | 0.63 (0.43; 0.93) |
0.019
|
0.028
|
TT | 0.286 | 1.43 (1.01; 2.02) |
0.044
| 0.120 | 1.64 (1.09; 2.46) |
0.017
|
0.028
|
AT | 0.343 | 0.99 (0.73; 1.37) | 0.973 | 0.973 | 1.07 (0.74; 1.54) | 0.708 | 0.708 |
- Abbreviations: aOR Adjusted odds ratio, 95 CI 95% confidence interval, HIV Human immunodeficiency virus, DBP Vitamin D binding protein, LTNPs Long term non progressors, MPs moderate progressor, RPs Rapid progressor.
- Statistics: P-values were calculated using PLINK software by logistic regression adjusted by gender, age at HIV diagnosis, men who had sex with men and VDR rs2228570 polymorphism.
- (*)raw p-values
- (**)p-values corrected for multiple testing (q-value) using the false discovery rate (FDR) with Benjamini and Hochberg procedure (n = 3 haplotypes, multiple comparisons). Statistically significant differences are shown in bold.